These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31651045)

  • 21. Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016 - The Center for Cardio-metabolic Risk Reduction in South Asia Study.
    Anjana RM; Deepa M; Subashini R; Patel SA; Kondal D; Unnikrishnan R; Tandon N; Prabhakaran D; Narayan KMV; Kadir MM; Mohan V; Ali MK
    Diabet Med; 2021 Feb; 38(2):e14424. PubMed ID: 33067811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socio-economic differences in cardiovascular disease risk factor prevalence in people with type 2 diabetes in Scotland: a cross-sectional study.
    Whittaker E; Read SH; Colhoun HM; Lindsay RS; McGurnaghan S; McKnight JA; Sattar N; Wild SH;
    Diabet Med; 2020 Aug; 37(8):1395-1402. PubMed ID: 32189372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.
    Shi L; Ye X; Lu M; Wu EQ; Sharma H; Thomason D; Fonseca VA
    Diabetes Care; 2013 Oct; 36(10):3297-304. PubMed ID: 23801723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study.
    Xu S; Sun F; Xu W; Jiao K; Shi B; Xie X; Wang Y; Zhu M; Ji Q
    Niger J Clin Pract; 2016; 19(6):784-792. PubMed ID: 27811452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a multicomponent intervention on achievement and improvements in quality-of-care indices among people with Type 2 diabetes in South Asia: the CARRS trial.
    Shah MK; Kondal D; Patel SA; Singh K; Devarajan R; Shivashankar R; Ajay VS; Menon VU; Varthakavi PK; Viswanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Tandon N; Ali MK
    Diabet Med; 2020 Nov; 37(11):1825-1831. PubMed ID: 31479537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 diabetes management: Room for improvement.
    Varkevisser RDM; Birnie E; Mul D; van Dijk PR; Aanstoot HJ; Wolffenbuttel BHR; van der Klauw MM
    J Diabetes; 2023 Mar; 15(3):255-263. PubMed ID: 36808864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving diabetes treatment targets in people with registered mental illness is similar or improved compared with those without: Analyses of linked observational datasets.
    Nieuwenhuijse EA; Struijs JN; Sutch SP; Numans ME; Vos RC
    Diabet Med; 2022 Jun; 39(6):e14835. PubMed ID: 35342984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes.
    Ibáñez B; Galbete A; Goñi MJ; Forga L; Arnedo L; Aizpuru F; Librero J; Lecea O; Cambra K
    BMC Public Health; 2018 Mar; 18(1):408. PubMed ID: 29587788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting American Diabetes Association diabetes management targets: trends in Mauritius.
    Tabesh M; Shaw JE; Zimmet PZ; Soderberg S; Kowlessur S; Timol M; Joonas N; Alberti GMM; Tuomilehto J; Shaw BJ; Magliano DJ
    Diabet Med; 2017 Dec; 34(12):1719-1727. PubMed ID: 28792634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes.
    Bashier AM; Abdelgadir EI; Khalifa AA; Rashid F; Abuelkeir SM; Bachet FE
    Saudi Med J; 2014 Nov; 35(11):1404-7. PubMed ID: 25399222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study.
    Lv F; Cai X; Hu D; Pan C; Zhang D; Xu J; Ji L
    J Diabetes Res; 2019; 2019():5631620. PubMed ID: 31828163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate achievement of ABC goals (HbA1c, blood pressure, LDL-C) among patients with type 2 diabetes in an Iranian population, 2012-2017.
    Larry M; Alizadeh S; Naderi S; Salekani B; Mansournia MA; Rabizadeh S; Esteghamati A; Nakhjavani M
    Diabetes Metab Syndr; 2020; 14(4):619-625. PubMed ID: 32422446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achievement of treatment targets among patients with type 2 diabetes in 2015 and 2020 in Canadian primary care.
    Nandiwada S; Manca DP; Yeung RO; Lau D
    CMAJ; 2023 Jan; 195(1):E1-E9. PubMed ID: 36623861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care.
    Baharudin N; Ramli AS; Ramland SS; Badlie-Hisham NI; Mohamed-Yassin MS
    J Prim Care Community Health; 2023; 14():21501319231191017. PubMed ID: 37551146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of standardized nursing care plans to achieve A1C, blood pressure, and LDL-C goals among people with poorly controlled type 2 diabetes mellitus at baseline: four-year follow-up study.
    Cárdenas-Valladolid J; López-de Andrés A; Jiménez-García R; de Dios-Duarte MJ; Gómez-Campelo P; de Burgos-Lunar C; San Andrés-Rebollo FJ; Abánades-Herranz JC; Salinero-Fort MA
    BMC Fam Pract; 2018 Jul; 19(1):125. PubMed ID: 30041600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.